TCL Archive Marker Research Plans Described; NCAB May Consider Asking For Special Study Section For Those Grants March 11, 1983
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004